These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Modern therapeutic viewpoints in the treatment of multiple sclerosis]. Neumayer E Wien Med Wochenschr; 1969 Apr; 119(15):281-4. PubMed ID: 5769603 [No Abstract] [Full Text] [Related]
23. Immunotherapy for multiple sclerosis: the curious case of interferon beta. Stüve O; Ransohoff RM Arch Neurol; 2009 Oct; 66(10):1193-4. PubMed ID: 19822773 [No Abstract] [Full Text] [Related]
24. Early multiple sclerosis: to treat or not to treat? Roach ES Arch Neurol; 2006 Apr; 63(4):619. PubMed ID: 16606782 [No Abstract] [Full Text] [Related]
25. New treatments for multiple sclerosis. Poirier J Axone; 1999 Mar; 20(3):78-9. PubMed ID: 10401269 [No Abstract] [Full Text] [Related]
26. [Multiple sclerosis. Studies on etiology and therapy]. Bauer HJ MMW Munch Med Wochenschr; 1982 Jan; 124(4):69-70. PubMed ID: 6801481 [No Abstract] [Full Text] [Related]
27. [Multiple sclerosis]. Itoyama Y No To Shinkei; 2000 Dec; 52(12):1051-5. PubMed ID: 11193536 [No Abstract] [Full Text] [Related]
29. Reason for hope: the advent of disease-modifying therapies in multiple sclerosis. O'Connor PW CMAJ; 2000 Jan; 162(1):83-4. PubMed ID: 11216206 [No Abstract] [Full Text] [Related]
30. [Induction of tolerance of heterologous protein in therapy with antilymphocytic globulin in man]. Tilz GP Med Klin; 1972 Mar; 67(12):410-3. PubMed ID: 4112374 [No Abstract] [Full Text] [Related]
31. Multiple sclerosis. Treatment is shifting. Mayo Clin Health Lett; 2003 Jan; 21(1):6. PubMed ID: 12619619 [No Abstract] [Full Text] [Related]
32. [Aspects of immunosuppressive therapy of multiple sclerosis]. Fischer W Psychiatr Neurol Med Psychol Beih; 1975; 20-21():23-6. PubMed ID: 829627 [TBL] [Abstract][Full Text] [Related]
33. High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis. Kozák T; Havrdová E; Pit'ha J; Gregora E; Pytlík R; Maaloufová J; Marecková H; Kobylka P; Vodvárková S Bone Marrow Transplant; 2000 Mar; 25(5):525-31. PubMed ID: 10713630 [TBL] [Abstract][Full Text] [Related]
34. From etiology and pathogenesis to therapy of multiple sclerosis. Cazzullo CL Boll Ist Sieroter Milan; 1978 Jan; 56(6):622-33. PubMed ID: 580220 [TBL] [Abstract][Full Text] [Related]
35. Immunotherapy of multiple sclerosis--current practice and future directions. Tullman MJ; Lublin FD; Miller AE J Rehabil Res Dev; 2002; 39(2):273-85. PubMed ID: 12051470 [TBL] [Abstract][Full Text] [Related]